Related Experiment Videos
Fibrinogen Chapel Hill: hypodysfibrinogenemia with a tertiary polymerization defect
American Journal of Hematology
|January 1, 1980
Summary
Fibrinogen Chapel Hill, a rare fibrinogen defect, causes impaired fibrin clot formation due to polymerization issues. This impacts fibrinolysis and proteolysis, highlighting an alpha chain abnormality.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- Fibrinogen is a crucial protein for blood clot formation.
- Defects in fibrinogen can lead to bleeding disorders or thrombosis.
- Fibrinogen Chapel Hill presents as a hypofibrinogenemia with functional deficits.
Observation:
- Investigated a patient with functionally defective fibrinogen (Chapel Hill).
- Observed hypofibrinogenemia with normal fibrinogen survival and fibrinopeptide release.
- Identified a polymerization defect leading to delayed fibrin gel formation.
Findings:
- The defect stems from an abnormality in a tertiary contact site within the alpha chain's hydrophilic, carboxy-terminal segment.
- Delayed plasmin cleavage of fibrinogen and fragment X, impacting subsequent fragment generation (Y, D, E).
- Demonstrated unusual sensitivity to Ancrod proteolysis, with rapid cleavage of the alpha chain's carboxy-terminal segment.
Implications:
- Structural abnormality in the alpha chain's polymerization domain explains observed functional deficits.
- Provides insights into fibrinogen structure-function relationships and clot polymerization mechanisms.
- Understanding such defects is vital for diagnosing and managing rare bleeding disorders.